The Union Cabinet chaired by Prime Minister Narendra Modi on Wednesday approved the continuation of the Biomedical Research Career Programme (BRCP), Phase III, to be implemented between 2025-26 and 2030-31, with an additional six-year support period until 2037-38. The programme, launched in partnership between the Department of Biotechnology (DBT), the Wellcome Trust (UK), and the DBT/Wellcome Trust India Alliance, will have a total outlay of ₹1,500 crore, of which DBT will contribute ₹1,000 crore and the Wellcome Trust ₹500 crore.

The BRCP, first launched in 2008-09 and expanded in 2018-19, has positioned India as an emerging hub for biomedical sciences of global repute. With Phase III, the government aims to further strengthen India’s scientific ecosystem in line with the goals of Viksi

See Full Page